Clinical trial

Assessment System of Sarcopenia in Lung Cancer Patients

NCT06327594

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention ultrasound scan Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention CT/MRI scan Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Assessment System of Sarcopenia in Lung Cancer Patients

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2023-11-01

PhaseN/A

Conditions

Sarcopeniaunresolved

Lung Cancerverified · MONDO: lung cancer

Ultrasoundunresolved

Interventions

ultrasound scanDIAGNOSTIC_TEST

CT/MRI scanDIAGNOSTIC_TEST

Sponsors & collaborators

West China Hospitallead sponsor

Mapped research locations

ChengduSichuan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06327594 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.